Robert J. Lynch

1.5k total citations
38 papers, 1.2k citations indexed

About

Robert J. Lynch is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Robert J. Lynch has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Molecular Biology. Recurrent topics in Robert J. Lynch's work include Platelet Disorders and Treatments (17 papers), Cell Adhesion Molecules Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert J. Lynch is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Cell Adhesion Molecules Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert J. Lynch collaborates with scholars based in United States, Saudi Arabia and New Zealand. Robert J. Lynch's co-authors include George D. Hartman, Melissa S. Egbertson, Wasyl Halczenko, David N. Glass, William L. Laswell, Joseph J. Lynch, R J Gould, Adel M. Naylor, Marie A. Holahan and Robert L. Smith and has published in prestigious journals such as Physics Today, Journal of Medicinal Chemistry and Infection and Immunity.

In The Last Decade

Robert J. Lynch

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Lynch United States 20 406 394 262 240 185 38 1.2k
John L. Krstenansky United States 26 194 0.5× 1.1k 2.8× 270 1.0× 45 0.2× 49 0.3× 73 1.8k
Lorraine Malkowitz United States 17 142 0.3× 554 1.4× 30 0.1× 116 0.5× 16 0.1× 22 1.5k
Lee W. Slice United States 21 71 0.2× 1.1k 2.9× 22 0.1× 60 0.3× 43 0.2× 30 1.7k
Yoshito Numata Japan 23 172 0.4× 627 1.6× 18 0.1× 26 0.1× 43 0.2× 46 1.2k
Peter J. Manley United States 14 316 0.8× 284 0.7× 45 0.2× 45 0.2× 69 0.4× 18 715
Benjamin Rivnay United States 19 54 0.1× 711 1.8× 55 0.2× 44 0.2× 15 0.1× 51 1.3k
Peter Aadal Nielsen Denmark 20 312 0.8× 1.1k 2.9× 21 0.1× 22 0.1× 19 0.1× 41 1.6k
Filip Goossens Belgium 18 83 0.2× 610 1.5× 160 0.6× 18 0.1× 71 0.4× 37 1.5k
Fanny Norris Denmark 14 59 0.1× 789 2.0× 172 0.7× 31 0.1× 18 0.1× 17 1.5k
Tomoko Nomura Japan 17 139 0.3× 535 1.4× 67 0.3× 16 0.1× 59 0.3× 34 906

Countries citing papers authored by Robert J. Lynch

Since Specialization
Citations

This map shows the geographic impact of Robert J. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Lynch more than expected).

Fields of papers citing papers by Robert J. Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Lynch. The network helps show where Robert J. Lynch may publish in the future.

Co-authorship network of co-authors of Robert J. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Lynch. A scholar is included among the top collaborators of Robert J. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Lynch. Robert J. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Robert J., et al.. (2023). From Rifts to Rapport: A Personal-Disclosure Mutual-Sharing (PDMS) Mindfulness Intervention for Enhancing Cohesion in Mixed-Gender, Coactive Teams. Journal of Sport Psychology in Action. 15(3). 165–176. 1 indexed citations
2.
Karczewski, Jerzy, Laszlo Kiss, Stefanie A. Kane, et al.. (2008). High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5. Biochemical Pharmacology. 77(2). 177–185. 11 indexed citations
3.
Coleman, Paul J., Ben Askew, John H. Hutchinson, et al.. (2002). Non-Peptide αvβ3 Antagonists. Part 4: Potent and Orally Bioavailable Chain-Shortened RGD Mimetics. Bioorganic & Medicinal Chemistry Letters. 12(17). 2463–2465. 26 indexed citations
4.
Lynch, Robert J., et al.. (1999). The impact of the National Weeds Strategy on weed management within Australia.. 490–495. 4 indexed citations
5.
Hartman, George D., Mark E. Duggan, William F. Hoffman, et al.. (1999). Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(6). 863–868. 4 indexed citations
6.
Egbertson, Melissa S., Jacquelynn J. Cook, Bohumil Bednář, et al.. (1999). Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation. Journal of Medicinal Chemistry. 42(19). 4014–4014. 2 indexed citations
7.
Liverton, Nigel J., David A. Claremon, David C. Remy, et al.. (1998). Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 483–486. 105 indexed citations
8.
Lynch, Joseph J., Jacquelynn J. Cook, Gary R. Sitko, et al.. (1995). Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 20–32. 56 indexed citations
9.
DUGGAN, M. E., Adel M. Naylor-Olsen, James J. Perkins, et al.. (1995). ChemInform Abstract: Non‐Peptide Fibrinogen Receptor Antagonists. Part 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor Antagonist.. ChemInform. 26(51). 1 indexed citations
10.
Egbertson, Melissa S., R J Gould, Wasyl Halczenko, et al.. (1994). Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp. Journal of Medicinal Chemistry. 37(16). 2537–2551. 147 indexed citations
11.
Ramjit, Denise, Joseph J. Lynch, Gary R. Sitko, et al.. (1993). Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.. Journal of Pharmacology and Experimental Therapeutics. 266(3). 1501–1511. 26 indexed citations
12.
Ashton, Wallace T., et al.. (1992). Inhibitors of human renin with C-termini derived from amides and esters of .alpha.-mercaptoalkanoic acids. Journal of Medicinal Chemistry. 35(15). 2772–2781. 11 indexed citations
13.
Hartman, George D., Melissa S. Egbertson, Wasyl Halczenko, et al.. (1992). Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors. Journal of Medicinal Chemistry. 35(24). 4640–4642. 231 indexed citations
14.
Ashton, Wallace T., Laura C. Meurer, Richard L. Tolman, et al.. (1992). Renin inhibitors containing C-termini derived from mercaptoheterocycles. Journal of Medicinal Chemistry. 35(11). 2103–2112. 28 indexed citations
15.
Williams, Peter D., Debra S. Perlow, Linda S. Payne, et al.. (1991). Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics. Journal of Medicinal Chemistry. 34(3). 887–900. 31 indexed citations
16.
Weber, Ann E., Thomas A. Halgren, John Doyle, et al.. (1991). Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors. Journal of Medicinal Chemistry. 34(9). 2692–2701. 40 indexed citations
17.
Hofmann, Kathryn J., Paul M. Keller, Mark A. Polokoff, et al.. (1990). Regulated production of recombinant echistatin by yeast. Biotechnology Letters. 12(12). 879–884. 5 indexed citations
18.
Puchalski, Wolfgang & Robert J. Lynch. (1988). Daily Melatonin Injections Affect the Expression of Circadian Rhythmicity in Djungarian Hamsters Kept under a Long-Day Photoperiod. Neuroendocrinology. 48(3). 280–286. 41 indexed citations
19.
Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1987). Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini. Journal of Medicinal Chemistry. 30(10). 1853–1857. 9 indexed citations
20.
Martinez, Douglas, et al.. (1980). Macrophage Dependence of Polyriboinosinic Acid-Polyribocytidylic Acid-Induced Resistance to Herpes Simplex Virus Infection in Mice. Infection and Immunity. 28(1). 147–153. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Krstenansky Breakdown of academic impact, for papers by Lorraine Malkowitz Breakdown of academic impact, for papers by Lee W. Slice Breakdown of academic impact, for papers by Yoshito Numata Breakdown of academic impact, for papers by Peter J. Manley Breakdown of academic impact, for papers by Benjamin Rivnay Breakdown of academic impact, for papers by Peter Aadal Nielsen Breakdown of academic impact, for papers by Filip Goossens Breakdown of academic impact, for papers by Fanny Norris Breakdown of academic impact, for papers by Tomoko Nomura
Rankless by CCL
2026